A company’s technology strategy determines its ability to create value over time. Frankel Group works with senior leadership teams not simply to create better products and services, but to create better companies. Our analysis begins with scenario-based assessments of the future global demographic, economic, epidemiological, technological, political, and social trends that will define the competitive ecosystem. We review best practices in the application of innovation, looking not only at life sciences but at other technology business sectors. Ultimately, our engagements result in a series of both technical and organizational investment recommendations.
Services provided are both inward and outward looking:
- Disease characterization and target prioritization
- Unmet needs identification and evolution
- Global landscape/trend analyses and scenario development
- Competitive evaluation
- Best practice benchmarking
- Organizational and technological capability review
- Tailored platform and business model investment recommendations
